BAM
CORT icon

Blueshift Asset Management’s Corcept Therapeutics CORT Stock Holding History

Blueshift Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,957
Closed -$382K – 735
2022
Q1 		$382K Buy
+16,957
New +$361K 0.03% 527
2021
Q4 		– Sell
-17,566
Closed -$346K – 907
2021
Q3 		$346K Sell
17,566
-12,257
-41% -$257K 0.02% 763
2021
Q2 		$656K Buy
29,823
+12,641
+74% +$281K 0.04% 475
2021
Q1 		$409K Buy
+17,182
New +$459K 0.04% 540
2020
Q1 		– Sell
-26,668
Closed -$323K – 285
2019
Q4 		$323K Buy
+26,668
New +$371K 0.04% 584

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return